Cortechs.ai | NeuroQuant<sup>®</sup> MS performance evaluation

NeuroQuant® MS performance evaluation

Quantitative measurements of lesion volume and lesion distribution have significant value for clinicians evaluating disease progression. Subjective measurements based on a clinician’s visual inspection and manual lesion segmentation are often vulnerable to inter-and intra-rater variability, resulting in low reproducibility. Thus, objective, automated lesion segmentation tools have been developed [1-3] to overcome these problems. Since the appearance of lesions may vary across different MRI protocols, incorporating multiple MRI studies provides more information to accurately delineate lesions.


More Resources

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

11/17/2025

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Discover how Imaging Healthcare Specialists integrated OnQ™ Prostate to enhance lesion visibility, boost diagnostic confidence, and improve communication.

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision
Scroll to Top